• 1. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 2. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 3. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

(2S,4R)-2-Amino-4-Methylpentanedioic Acid: A Comprehensive Overview

(2S,4R)-2-Amino-4-Methylpentanedioic Acid, also known by its CAS registry number CAS No. 33511-70-5, is a unique amino acid derivative that has garnered significant attention in the fields of biochemistry and pharmacology. This compound is characterized by its chiral centers and functional groups, which contribute to its diverse biological activities and potential applications in drug development and nutraceuticals.

The molecular structure of (2S,4R)-2-Amino-4-Methylpentanedioic Acid consists of a pentanedioic acid backbone with an amino group at the second carbon and a methyl group at the fourth carbon. The stereochemistry of this compound, specifically the (2S,4R) configuration, plays a crucial role in determining its interactions with biological systems. Recent studies have highlighted its ability to act as a precursor for various bioactive molecules, making it a valuable compound in both research and industrial settings.

One of the most notable aspects of this compound is its role in metabolic pathways. Researchers have demonstrated that (2S,4R)-2-Amino-4-Methylpentanedioic Acid can influence cellular energy production by modulating key enzymes involved in mitochondrial function. This finding has implications for its potential use in treating metabolic disorders such as obesity and type 2 diabetes.

In addition to its metabolic effects, this compound has shown promise in the field of neuroscience. Preclinical studies indicate that it may enhance cognitive function by improving synaptic plasticity and reducing oxidative stress in neuronal cells. These properties suggest that it could be developed into a therapeutic agent for neurodegenerative diseases such as Alzheimer's and Parkinson's.

The synthesis of (2S,4R)-2-Amino-4-Methylpentanedioic Acid involves advanced stereochemical control techniques to ensure the correct configuration of the chiral centers. Recent advancements in asymmetric catalysis have made it possible to produce this compound on an industrial scale with high enantiomeric purity, which is essential for maintaining its biological activity.

From an environmental perspective, this compound has been studied for its biodegradability and ecological impact. Research indicates that it is readily metabolized by microorganisms under aerobic conditions, making it an eco-friendly option for use in pharmaceuticals and food additives.

In conclusion, (2S,4R)-2-Amino-4-Methylpentanedioic Acid (CAS No. 33511-70-5) is a versatile compound with significant potential in multiple areas of science and industry. Its unique chemical properties, combined with recent breakthroughs in synthesis and application research, position it as a key player in the development of novel therapeutics and nutraceuticals.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)